Founder of healthcare automation startup using AI agents to navigate insurance and supply chain for patient drug access; raised $150M Series C at $3B valuation.
no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY
AI agents per restriction navigate complex insurance, affordability, and supply chain barriers so patients actually receive prescribed therapies; starting in autoimmune specialties and expanding to oncology, neurology, and all 50 states.